Notice of Intent: LUTATHERA� (lutetium Lu 177 dotatate) and PLUVICTO� (lutetium Lu 177 vipivotide tetraxetan)

Frist:04 Jun 2026, 17:00 GMT-4

Ausschreibungsinformationen

SAM.gov

FALLS CHURCH, United States

Art: Special Notice
Verfahren: Special Notice
Referenznummer: 47ec968c84524dd3995719d89e75155a
NAICS: 325412

The Defense Health Agency (DHA), Healthcare Contracting Division � Northeast (HCD-NE), Department of Radiology at Walter Reed National Military Medical Center (WRNMMC), intends to award a firm fixed price contract on a s…

ole source basis to Novartis Pharmaceuticals Corporation (Cage: 04520). The anticipated award will be made under the statutory authority permitting Other than Full and Open Competition pursuant to FAR 6.302-1 �Only one responsible source and no other supplies or services will satisfy agency requirem

ents�. The contract is intended to procure LUTATHERA� (lutetium Lu 177 dotatate) and PLUVICTO� (lutetium Lu 177 vipivotide tetraxetan) exclusively developed, manufactured, and supplied by Novartis Pharmaceuticals Corporation (Cage: 04520).

Alle Ausschreibungsinformationen anzeigen

Dokumente

Alle wichtigen Termine anzeigen